(19)
(11) EP 1 440 709 A3

(12) EUROPEAN PATENT APPLICATION

(88) Date of publication A3:
08.12.2004 Bulletin 2004/50

(43) Date of publication A2:
28.07.2004 Bulletin 2004/31

(21) Application number: 04010436.6

(22) Date of filing: 17.10.2000
(51) International Patent Classification (IPC)7A61P 25/02, A61K 31/00, A61K 31/519, A61K 31/19
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

(30) Priority: 21.10.1999 GB 9924958
01.09.2000 GB 0021520

(62) Application number of the earlier application in accordance with Art. 76 EPC:
00309129.5 / 1129706

(71) Applicants:
  • Pfizer Limited
    Sandwich, Kent CT13 9NJ (GB)

    GB 
  • PFIZER INC.
    New York, N.Y. 10017 (US)

    AT BE CH LI CY DE DK ES FI FR GR IE IT LU NL PT SE 

(72) Inventors:
  • Forster, Eliot Richard
    Sandwich, Kent CT13 9NJ (GB)
  • Koppiker, Nandan Parmanand
    Sandwich, Kent CT13 9NJ (GB)

(74) Representative: Stuart, Peter Graham 
Pfizer Limited, European Patents Department, Ramsgate Road
Sandwich, Kent CT13 9NJ
Sandwich, Kent CT13 9NJ (GB)

   


(54) Combinations comprising cGMP PDE5 inhibitors.


(57) The present invention describes a combination comprising a c-GMP PDE5 inhibitor with gabapentin or pregabalin, particularly for the treatment of neuropathy.





Search report